On Kratom, or The Fractured Regulation of Unscheduled Drugs
The Rockefeller Institute looks at the increasing concerns about the derivatives of kratom that have prompted executive and legislative action at the federal, state, and local levels.
The Rockefeller Institute looks at the increasing concerns about the derivatives of kratom that have prompted executive and legislative action at the federal, state, and local levels.
Recent actions taken by the federal government will affect New York State's 1115 Medicaid waiver; this blog presents opportunities to align the waiver with the federal government's policy goals.